We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFIN icon
1551
Medallion Financial
MFIN
$229M
$1.22M ﹤0.01%
153,643
+58,766
+62% +$528K
JJSF icon
1552
J&J Snack Foods
JJSF
$1.49B
$1.21M ﹤0.01%
8,392
-2,993
-26% -$452K
UNIT
1553
Uniti Group
UNIT
$2.53B
$1.21M ﹤0.01%
+205,454
New +$1.17M
KRRO icon
1554
Korro Bio
KRRO
$151M
$1.21M ﹤0.01%
+13,407
New +$732K
CCCC icon
1555
C4 Therapeutics
CCCC
$393M
$1.2M ﹤0.01%
146,644
-976,417
-87% -$7.57M
LXRX icon
1556
Lexicon Pharmaceuticals
LXRX
$1.04B
$1.2M ﹤0.01%
+499,172
New +$1.07M
AMWD
1557
DELISTED
American Woodmark
AMWD
$1.19M ﹤0.01%
11,744
-31,403
-73% -$2.96M
ATNM icon
1558
Actinium Pharmaceuticals
ATNM
$27.2M
$1.19M ﹤0.01%
+152,469
New +$980K
DADA
1559
DELISTED
Dada Nexus
DADA
$1.18M ﹤0.01%
+576,357
New +$1.23M
IBB icon
1560
CALL
iShares Biotechnology ETF
IBB
$9.55B
$1.18M ﹤0.01%
+8,700
New +$1.19M
IGF icon
1561
iShares Global Infrastructure ETF
IGF
$10.9B
$1.18M ﹤0.01%
+24,723
New +$1.14M
SITM icon
1562
SiTime
SITM
$14.7B
$1.17M ﹤0.01%
+12,599
New +$1.33M
GRNT icon
1563
Granite Ridge Resources
GRNT
$601M
$1.17M ﹤0.01%
180,573
-182,365
-50% -$1.07M
HHH icon
1564
Howard Hughes
HHH
$4B
$1.17M ﹤0.01%
16,883
-8,803
-34% -$653K
TGI
1565
DELISTED
Triumph Group
TGI
$1.17M ﹤0.01%
77,661
-102,869
-57% -$1.53M
ROAD icon
1566
Construction Partners
ROAD
$6.03B
$1.17M ﹤0.01%
20,789
-134,544
-87% -$6.36M
BAND
1567
Bandwidth Inc
BAND
$1.67B
$1.17M ﹤0.01%
+63,834
New +$1M
FELE icon
1568
Franklin Electric
FELE
$4.85B
$1.16M ﹤0.01%
+10,900
New +$1.08M
GOGO icon
1569
Gogo Inc
GOGO
$550M
$1.16M ﹤0.01%
+132,349
New +$1.19M
LWAY icon
1570
Lifeway Foods
LWAY
$470M
$1.16M ﹤0.01%
67,475
-24,275
-26% -$311K
SRG
1571
Seritage Growth Properties
SRG
$129M
$1.16M ﹤0.01%
120,404
-39,387
-25% -$370K
EMN icon
1572
Eastman Chemical
EMN
$7.79B
$1.16M ﹤0.01%
+11,578
New +$1.02M
MRNOW
1573
CALL
Murano Global Investments PLC Warrants
MRNOW
$218K
$1.15M ﹤0.01%
+99,852
New +$13.4K
EVBG
1574
DELISTED
Everbridge, Inc. Common Stock
EVBG
$1.15M ﹤0.01%
+32,900
New +$927K
SMWB icon
1575
Similarweb
SMWB
$630M
$1.14M ﹤0.01%
127,079
+79,556
+167% +$588K

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.